Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Carmot Therapeutics, Inc.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male or female, 18 years of age or older at the time of signing informed consent
Have a documented clinical diagnosis of T1DM greater than or equal to 1 year before the Screening Visit
Body mass index greater than or equal to27.0 kg/m2
Hemoglobin A1c (HbA1c) level between 7.0% and 10.0%, inclusive, at the Screening Visit
You may not be if
Diagnosis of Type 2 diabetes mellitus (T2DM) or any other types of diabetes, except T1DM
Experienced diabetic ketoacidosis (DKA) within 3 months prior to the Screening Visit
Experienced severe hypoglycemia (Level 3 as defined in the ADA Standards of Medical Care in Diabetes (ADA 2022) within 3 months prior to the Screening Visit
Clareo Health | A Study of CT-868 in Type 1 Diabetes Mellitus
